NEWS RELEASE: Creative Foam completes acquisition of AccuMED
Fenton, Michigan (March 5, 2025) – Creative Foam Corp. (“Creative Foam”) today announced that it has acquired AccuMED Holdings Corp. (“AccuMED” or the “Company”). This marks Creative Foam’s fourth acquisition in the medical device industry.
AccuMed partners with top medtech companies to provide contract manufacturing and engineering services, specializing in textile-based Class I and II medical devices. Manufacturing capabilities include lamination, RF welding, cutting and sewing, and kitting operations, among others. With 24 years of operation in the Dominican Republic, AccuMED employs approximately 1,400 skilled professionals utilizing over 70 production lines in FDA-registered and ISO 13485 facilities.
“We remain focused on the continued growth of our Medical Division, both organically and through acquisition, and believe AccuMed is a highly strategic fit,” said Koen Devits, president and CEO of Creative Foam. “The acquisition of AccuMed not only expands our Medical Division’s customer base and combined capabilities but enhances our ability to serve customers looking to near-shore programs with low-cost country manufacturing.”
About the company
Creative Foam is a manufacturer and supplier of custom-engineered die-cut, formed foam, nonwoven and multi-material component solutions to the transportation, medical, and Industrial markets. The company was founded in 1969 and is headquartered in Fenton, Michigan. Its 12 facilities across North America, including in Michigan, Indiana, Ohio, Washington, Tennessee, and Mexico, feature over 1 million square feet of production space. For more information, visit the company’s website at www.creativefoam.com.
The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.
